Rankings
▼
Calendar
MIRM FY 2025 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MIRM
Mirum Pharmaceuticals, Inc.
$5B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$521M
+54.7% YoY
Gross Profit
$421M
80.7% margin
Operating Income
-$22M
-4.2% margin
Net Income
-$23M
-4.5% margin
EPS (Diluted)
$-0.47
Cash Flow
Operating Cash Flow
$56M
Free Cash Flow
$55M
Stock-Based Comp.
$71M
Balance Sheet
Total Assets
$843M
Total Liabilities
$528M
Stockholders' Equity
$315M
Cash & Equivalents
$297M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$521M
$337M
+54.7%
Gross Profit
$421M
$255M
+64.8%
Operating Income
-$22M
-$88M
+74.7%
Net Income
-$23M
-$88M
+73.4%
← Q4 2024
All Quarters
Q1 2025 →